Market Place
Sourcing Support
Class Action Over Generic Clobetasol And Clomipramine
06 May 2025 //
PR NEWSWIRE
Actavis Settles Intuniv Generic-Delay Claims for $1.1 Million
25 May 2021 //
BLOOMBERGLAW
Nalproprion Pharmaceuticals, Inc. v. Actavis Laboratories FL, Inc.
22 Aug 2019 //
PATENT DOCS
Sanofi patent case win holds off generic rivals for key cancer drug
16 Aug 2019 //
PMLIVE
More Pain for Warner-Lambert and Their Pregabalin Patent
07 Feb 2019 //
PATENT DOCS
FTC Approves Teva Petition to reopen Watson Pharms’ Acquisition of Actavis case
20 Dec 2018 //
FTC GOV
Aggrastat (tirofiban hydrochloride) : Medicure vs. Gland Pharma
24 Nov 2018 //
PATENT LITIGATION
Pfizer loses drug patent fight in UK top court, may face claims
15 Nov 2018 //
REUTERS
Teva asks FTC to reopen Actavis and Watson merger decision
24 Oct 2018 //
FTC GOV
Allergan architect Bisaro exits board as revamp continues
30 Aug 2018 //
FIERCE PHARMA
Uceris (budesonide) : Valeant Pharmaceuticals et al v. Teva Pharmaceuticals et al
27 Aug 2018 //
PATENT LITIGATION
Actavis At 5: Where Pay-For-Delay Litigation Stands
07 Aug 2018 //
LAW360
Rytary® (Levodopa/Carbidopa) Capsules: Impax Lab, v. Actavis Laboratories
17 May 2018 //
PATENT LITIGATION
Suboxone® (buprenorphine HCL & naloxone HCL)): Indivior v. Actavis Laboratories
07 Feb 2018 //
PATENT LITIGATION
Celgene Settlement With Actavis Allows Abraxane Generics In 2022
26 Jan 2018 //
PHARMAINTELLIGENCE
Bisaro, Amneal poach top Allergan exec for CEO`s chair
19 Dec 2017 //
FIERCE PHARMA
Soolantra® ( (Ivermectin): Galderma Lab v. Actavis Lab Teva Pharma USA
11 Dec 2017 //
PATENT LITIGATION
Teva Pharm overhauls structure and top management
28 Nov 2017 //
REUTERS
Alimta® (Pemetrexed): Eli Lilly V. Actavis , Tevapharmaceutical
16 Nov 2017 //
PATENT LITIGATION
Cost cuts are coming for Allergan, CEO says
02 Nov 2017 //
FIERCE PHARMA
Indivior reaches settlement with Mylan over patent dispute
26 Sep 2017 //
PHARMAFILE
Teva Hit With Investor Suit Over $40.5B Actavis Merger
31 Aug 2017 //
LAW361
Lilly victorious in Alimta patent case
11 Jul 2017 //
PHARMA TIMES
Gilead to launch injunction against Mylan & Actavis over HIV generics in Ireland
07 Jul 2017 //
PHARMAFILE
Brisdelle® (Paroxetine): Sebela Pharmaceuticals v. Actavis &Teva Pharmaceutical
28 Jun 2017 //
PATENT LITIGATION
Pregabalin: the battle continues
22 Jun 2017 //
PHARMA TIMES
Pennsaid® (Diclofenac Sodium ): Horizon Pharma & HZNP V. Actavis Laboratories
11 May 2017 //
PATENT LITIGATION
Rytary® (Levodopa/Carbidopa): Impax Laboratories, Inc. V. Actavis Laboratories
09 May 2017 //
PATENT LITIGATION
Soolantra® (Ivermectin): Galderma Laboratories,Nestle Skin Health & Actavis & Teva Inc.
21 Apr 2017 //
PATENT LITIGATION
Can ex-Actavis CEO Paul Bisaro work his growth magic at Impax?
27 Mar 2017 //
FIERCE PHARMA
Serial Testers and Cursory Checks: India`s Flawed Generic Drug Trials Business
28 Dec 2016 //
REUTERS
Teva Generics Europe appoints president and CEO
21 Dec 2016 //
PMLIVE
The Man The Feds Are Using To First Crack Open Their Big Antitrust Case
15 Dec 2016 //
FORBES
Teva Names Bhattacharjee as Generics Group Head, Replacing Olafsson
06 Dec 2016 //
REUTERS
Costco probed in Canada over alleged kickback scheme for generics
24 Nov 2016 //
STAT
U.S. Charges in Generic-Drug Probe to Be Filed by Year-End
04 Nov 2016 //
BLOOMBERG
Intas Pharma to acquire generics business of Actavis in UK & Ireland
06 Oct 2016 //
PHARMABIZ
$41B for Allergan`s generics business? Investors now say Teva `grossly` overpaid
01 Jun 2016 //
FIERCE PHARMA
United Files Citizen Petition Targeting Generics with ANDAs for Tyvaso
23 Jan 2016 //
TWOFOUR INSIGHT
FTC weigh in on Mylan case, saying generics tweaking may be anticompetitive
03 Oct 2015 //
FIERCE PHARMA
Actavis gets subpoena as DOJ probe of generic pricing moves up food chain
08 Aug 2015 //
FIERCE PHARMA
Two big problems with generic-drug substitution
23 Jun 2015 //
CNBC
FDA balks on generic Concerta as Mallinckrodt, Actavis meds gobble up market
18 Jun 2015 //
FIERCE PHARMA
Teva Pharma Announces U.S. Launch of Generic Actonel Tabs
01 Jun 2015 //
STREET INSIDER.COM
With A $1.2 Billion Hammer, The FTC Closes Loophole To Prevent Generic Drugs
29 May 2015 //
FORBES
Strides Arcolab to buy generic drugs business in Australia from Aspen Pharmacare
22 May 2015 //
THE ECONOMIC TIMES
Actavis Will Relaunch Generic Pulmicort Respules, Following Court Ruling
18 May 2015 //
FDA NEWS
HHS: Actavis could cost the government $6B with Namenda hard switch
11 May 2015 //
FIERCE PHARMA
Amneal Signs Deal to Acquire the Generic Business of Actavis Australia
30 Mar 2015 //
PHARMIWEB.COM
Actavis Confirms Generic Uceris® Patent Challenge
24 Feb 2015 //
PR NEWSWIRE
US Court Issues Temporary Injecton to Prevent Actavis for Distribution of Generic Pulmicort Respules
18 Feb 2015 //
PHARMABIZ
